Back
ESC2025 Premium Access

Indobufen-based dual antiplatelet therapy in patients with multivessel coronary disease undergoing drug-eluting stent implantation: insight from the OPTION trial

Session: Chronic coronary syndromes: antiplatelets
Topic: Pharmacotherapy
Speaker: Doctor L. Xu (Shanghai, CN)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Lili Xu

Zhongshan Hospital Fudan University, Shanghai (China)
0 follower

5 more presentations in this session

Antiplatelets and hemorrhagic MI outcome in reperfused STEMI

Speaker: Doctor K. Vora (Indianapolis, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Dual antiplatelet therapy de-escalation followed by aspirin or P2Y12 inhibitor monotherapy after PCI for acute coronary syndrome: a systematic review and meta-analysis

Speaker: Doctor C. Laudani (Catania, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Ticagrelor vs. clopidogrel in elderly patients following acute myocardial infarction: a multicenter international analysis

Speaker: Doctor R. Ibrahim (Phoenix, US)

Access
Abstract
Slides
Video
Like
Thumbnail

The effect of ticagrelor on patients with acute myocardial infarction and malnutrition

Speaker: Professor K. Chen (Tianjin, CN)

Access
Abstract
Slides
Video
Like
Thumbnail

Duration of dual antiplatelet therapy (DAPT) in patients undergoing percutaneous coronary intervention (PCI) for bifurcation lesions: insights from the ULTRA-BIFURCAT registry

Speaker: Doctor M. Nebiolo (Turin, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Chronic coronary syndromes: antiplatelets

Speakers: Doctor L. Xu, Doctor K. Vora, Doctor C. Laudani, Doctor R. Ibrahim, Professor K. Chen...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources